Literature DB >> 28796007

MRI scoring methods used in evaluation of muscle involvement in patients with idiopathic inflammatory myopathies.

Kateřina Kubínová1, Heřman Mann, Jiří Vencovský.   

Abstract

PURPOSE OF REVIEW: MRI is a promising imaging method commonly used to assess muscle involvement in patients with idiopathic inflammatory myopathies (IIM). MRI enables evaluation of both activity and damage and is therefore an ideal noninvasive diagnostic and monitoring tool. Despite its widespread use, there is no universally accepted method for scoring and reporting of MRI findings. The aim of this review is to provide an overview of systems used in the evaluation of MR images in patients with IIM. RECENT
FINDINGS: A number of semi-quantitative and quantitative methods have been used to evaluate and record the severity of myopathy on MRI. These scoring systems differ in the number and type of parameters assessed and in their complexity; furthermore, they were evaluated in different patient populations, all of which make comparisons between them difficult.
SUMMARY: There is a need to create a standardized and validated protocol for evaluation of pathological changes in muscle MRI in IIM. The most appropriate number and distribution of muscle groups as well as evaluated pathological features need to be determined. Based on this literature search, the future scoring system should include assessment of muscle oedema, fatty infiltration, muscle atrophy and possibly the presence of fascial and subcutaneous inflammation. Whether the quantitative methods provide more reliable information regarding disease activity remains unclear.

Entities:  

Mesh:

Year:  2017        PMID: 28796007     DOI: 10.1097/BOR.0000000000000435

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  6 in total

Review 1.  Update on outcome assessment in myositis.

Authors:  Lisa G Rider; Rohit Aggarwal; Pedro M Machado; Jean-Yves Hogrel; Ann M Reed; Lisa Christopher-Stine; Nicolino Ruperto
Journal:  Nat Rev Rheumatol       Date:  2018-04-12       Impact factor: 20.543

Review 2.  Advancements in magnetic resonance imaging-based biomarkers for muscular dystrophy.

Authors:  Doris G Leung
Journal:  Muscle Nerve       Date:  2019-05-14       Impact factor: 3.217

3.  Quantitative water T2 relaxometry in the early detection of neuromuscular diseases: a retrospective biopsy-controlled analysis.

Authors:  Noah Locher; Benedikt Wagner; Fabian Balsiger; Olivier Scheidegger
Journal:  Eur Radiol       Date:  2022-05-21       Impact factor: 5.315

4.  Novel Muscle Imaging in Inflammatory Rheumatic Diseases-A Focus on Ultrasound Shear Wave Elastography and Quantitative MRI.

Authors:  Matthew Farrow; John Biglands; Abdulrahman M Alfuraih; Richard J Wakefield; Ai Lyn Tan
Journal:  Front Med (Lausanne)       Date:  2020-08-12

Review 5.  Current Classification and Management of Inflammatory Myopathies.

Authors:  Jens Schmidt
Journal:  J Neuromuscul Dis       Date:  2018

6.  Diagnostic Value of Magnetic Resonance Imaging in Fibrodysplasia Ossificans Progressiva.

Authors:  Esmée Botman; Bernd P Teunissen; Pieter Raijmakers; Pim de Graaf; Maqsood Yaqub; Sanne Treurniet; Ton Schoenmaker; Nathalie Bravenboer; Dimitra Micha; Gerard Pals; Arend Bökenkamp; J Coen Netelenbos; Adriaan A Lammertsma; Elisabeth Mw Eekhoff
Journal:  JBMR Plus       Date:  2020-04-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.